Daihan Pharmaceutical Co. Ltd. closed an Equity Buyback in the amount of KRW770.46 mm
August 17, 2012 at 12:00 am EDT
Share
The Board of Directors of Daihan Pharmaceutical Co. Ltd. (KOSE:A023910) authorized a share repurchase program on July 5, 2012. Under the program, the company will repurchase up to 60,000 shares pursuant to a contract with Daewoo Securities Co., Ltd. The company will repurchase up to KRW 807 million worth of stock based on the closing price of July 4, 2012. Maximum number of shares that may be repurchased per day is 10,362. The shares will be purchased directly. The purpose behind the program is to stabilize the treasury stock price and improve corporate image. Repurchases will commence on July 10, 2012 and will continue until October 9, 2012. The company has no shares under the treasury. Daewoo Securities Co., Ltd. acted as investment broker in the transaction.
Daihan Pharmaceutical Co. Ltd. completed its share repurchase program on August 17, 2012. Under the program, the company has repurchased 60,000 shares for KRW 770.46 million.
DAIHAN PHARMACEUTICAL CO.,LTD. is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceuticals. The Company provides infusions, including basic infusions, nutritional infusions and infusions for special uses; injections for anesthetics, vitamin-minerals, autonomic nerve systems, hypnotic-sedatives, antispasmodics, antidotes, hormones, analgesics, respiratory and others; contrast media, such as drugs for computed tomography (CT) uses and magnetic resonance imaging (MRI) uses, and other drugs, such as drugs for irrigations, ointments, inhalants, as well as quasi-drugs such as hand gels, lens clean solutions and others.
DAIHAN PHARMACEUTICAL CO.,LTD. 
